Search for: "Janssen Research " Results 161 - 180 of 205
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Feb 2010, 8:00 am by Karen E. Keller
(patent infringement) 1/8: Alza Corporation and Ortho-McNeil-Janssen Pharmaceuticals Inc. v. [read post]
22 Dec 2015, 7:03 am by Dr. Shezad Malik
Xarelto was developed and sold jointly by Johnson & Johnson’s Janssen Pharmaceuticals subsidiary and Bayer Healthcare. [read post]
18 Oct 2014, 1:09 pm by Dr. Shezad Malik
Researchers found that over half of patients experienced symptoms lasting more than a year, and 80% characterized the nerve problems as severe. [read post]
18 Jul 2012, 2:59 am
"We must do more to protect our children from this dangerous chemical and the FDA must continue to aggressively pursue further research and action on BPA to protect the public health." [read post]
3 Jul 2016, 6:00 am by admin
Canagliflozina es fabricado y comercializado en México por el laboratorio Janssen, y fue aprobado en nuestro país antes de cualquier otro país latinoamericano. [read post]
24 Dec 2015, 6:43 am by Dr. Shezad Malik
Xarelto was developed and sold jointly by Johnson & Johnson’s Janssen Pharmaceuticals subsidiary and Bayer Healthcare. [read post]
29 Apr 2016, 11:51 am by highrank
Zofran Used for suppressing nausea, some research has linked this to birth defects in pregnant women. [read post]
21 Apr 2017, 6:25 am
Bulan, Cornerstone Research, on Tuesday, April 18, 2017 Tags: Accounting, Class actions, Derivative suits, Disclosure, Institutional Investors, Market reaction, Rule 10b-5, SEC, SEC enforcement, Section 11, Securities damages, Securities enforcement, Securities litigation, Securities regulation, Settlements Sustainability Matters: Focusing on your Future Today Posted by Elisse B. [read post]
21 Apr 2017, 6:25 am
Bulan, Cornerstone Research, on Tuesday, April 18, 2017 Tags: Accounting, Class actions, Derivative suits, Disclosure, Institutional Investors, Market reaction, Rule 10b-5, SEC, SEC enforcement, Section 11, Securities damages, Securities enforcement, Securities litigation, Securities regulation, Settlements Sustainability Matters: Focusing on your Future Today Posted by Elisse B. [read post]
20 Oct 2019, 7:35 pm by Jean O'Grady
You will also have the opportunity to see a sophisticated new approach to AI enabled legal research. [read post]
12 Jun 2019, 6:02 am by Martin Husovec
Overview Chair Academic1 Academic2 Industry1 Industry2 Industry3 Panel 1 General issues Husovec Janssens Nordemann  Google  TBD GEMA Panel 2 Licensing modalities Kretschmer Quintais Moscon Twitch EVA SACEM Panel 3 Preventive obligations Kretschmer Frosio Peguera Siteground ACTE STM Panel 4 Over-blocking Husovec Kuczerawy Margoni Communia IFPI BEUC Panel 1: General Issues In the policy debate about the effects of Article 17 (ex-Article 13) of the… [read post]
26 Feb 2016, 7:25 am by Brenda Fulmer
There are several depositions underway in New Jersey, Pennsylvania, and Amsterdam involving Bayer and Janssen’s employees. [read post]
13 Apr 2017, 4:25 am by Adrien Alberini
Article 3 of the Proposal for a Directive provides for a new exception to copyright aimed at allowing researchers to benefit from a clearer legal space to use innovative text and data mining research tools, teachers and students to be able to take full advantage of digital technologies at all levels of education and cultural heritage institutions (i.e. publicly accessible libraries or museums, archives or film or audio heritage institutions) to be supported in their efforts to… [read post]
10 May 2020, 4:28 pm by INFORRM
All  the Courts’ updates on the Coronavirus guidance can be found on the Courts and Tribunal Judiciary Hacked off had a press release “Hacked Off research reveals extent of relentless intrusion on singer Jesy Nelson”. [read post]
2 Sep 2015, 8:19 am by Ronald V. Miller, Jr.
  So in the past we have seen drugs rushed on to the market without the internal research necessary to make sure they are safe. [read post]
2 Sep 2015, 8:19 am by Ronald V. Miller, Jr.
  So in the past we have seen drugs rushed on to the market without the internal research necessary to make sure they are safe. [read post]
11 Jul 2017, 2:30 am by Kluwer UPC News blogger
According to research of IP Kat, and ‘if there are no further delays or unexpected hurdles, (…) it may be that the UK may have ratified the UPC by end of November/early December 2017’. [read post]